(Q93719275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4111245%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

title

Treatment of myasthenia gravis with prednisone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4111245%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

1 reference

R B Jenkins

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4111245%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

publication date

1 April 1972

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4111245%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4111245%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4111245%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

issue

7754

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4111245%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

page(s)

765-767

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4111245%20AND%20SRC:MED&resulttype=core&format=json

Effects of administration of the adrenocorticotropic hormone on patients with myasthenia gravis.

9 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

Studies in myasthenia gravis. Short-term massive corticotropin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

Corticotropin therapy in myasthenia gravis: effects, indications, and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

Corticotropin therapy and thymectomy in management of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

Treatment of ocular myasthenia with corticotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

Effects of cortisone in certain neuromuscular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

Clinical-evaluation of ACTH and cortisone in myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

Benefit from alternate-day prednisone in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

Aspects of Treatment of Crisis in Myasthenia Gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

The rationale of alternate-day corticosteroid therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990520-X

7 January 2021

10.1016/S0140-6736(72)90520-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4111245%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

1 reference